Decentralizing testing capacity of mpox in Africa: a narrative review.

Authors

Yao Selom Atrah, Nicksy Gumede, Joseph Nyombe, Nebiyu Dereje, Wazih N Cho, Kyeng Mercy, Michel Muteba, Jeanine Nkakulu Luzolo, Olga Ntumba-Tshitenge, Passy Kimema, Collins Kipngetich Tanui, Noah Takah Fongwen, Armel Mbouna, Rose Mary Nakame, Biruh Tesfaye Kebede, Yap Boum, Ngashi Ngongo, Mory Keita, Sofonias Kifle Tessema, Yenew Kebede Tebeje, Jean Kaseya

Published in

The Lancet regional health. Africa. Volume 5. Pages None.

Abstract

Decentralized diagnostics are essential for the timely detection and control of mpox outbreaks. Burundi and the Democratic Republic of Congo (DRC) transitioned from centralized testing to decentralized models using GeneXpert platforms, mobile labs, and real-time feedback systems. Burundi expanded from one to 56 diagnostic sites, reducing site-level turnaround times to 2-4 h and achieving nearly 100% testing coverage. The DRC scaled up from 2 to 28 labs, deploying multiplex platforms and stabilizing testing rates. Genomic surveillance also advanced, with over 3000 mpox virus (MPXV) genomes sequenced across 23 countries, revealing new clades and informing public health responses. Africa reached the 8% sequencing threshold, enabling real-time viral tracking. The mpox epidemic accelerated reforms, including continental guidelines for laboratory decentralization and the launch of a new initiative to expand testing, training, and local manufacturing. This article describes the mpox laboratory decentralization efforts, achievements, lessons, and best practices across Africa.

PMID:
42434479
Bibliographic data and abstract were imported from PubMed on 11 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.